What is Ixazomib?

Category: Prescription Drugs

Most popular types: Ninlaro

false

Ixazomib is a proteasome inhibitor used in combination with other drugs (lenalidomide and dexamethasone) to treat multiple myeloma in patients who have tried at least one other treatment previously.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
1
Moderate
2
Mild
0
None
1

Commonly reported side effects and conditions associated with Ixazomib

Side effect Patients
Diarrhea 1
Exploding headaches 1
Fatigue 1
Nausea 1
Neuropathy 1

Dosages

Based on patients currently taking Ixazomib

Dosage Patients
4 mg weekly 4
3 mg weekly 1
28 mg weekly 1

Why patients stopped taking Ixazomib

Multiple reasons could be selected

Reason Patients
Did not seem to work 1
See 1 patient who's stopped taking Ixazomib

Duration

Currently taking Ixazomib

Duration Patients
1 - 6 months 1
6 months - 1 year 1
1 - 2 years 3
2 - 5 years 1

Stopped taking Ixazomib

Duration Patients
6 months - 1 year 1
Adherence
Adherence Evaluations
Always 4
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 3
A little hard to take 0
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 2
< $25 0
Not specified 2

What people switch to and from

Patients started taking Ixazomib after stopping:

Treatment Patients
Carfilzomib (Kyprolis) 2
Lenalidomide (Revlimid) 2
Pomalidomide (Pomalyst) 2
Bortezomib-lenalidomide-dexamethasone (VRd) 1

Patients stopped taking Ixazomib and switched to:

Treatment Patients
Carfilzomib (Kyprolis) 1
Daratumumab (Darzalex) 1
Last updated:
There are no evaluations for Ixazomib.